Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Ophthalmic Solution for Blepharitis
NCT01269658Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Dec 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of AzaSite in blepharitis, sponsored by Merck & Co. Primary endpoint: Resolution of clinical signs of blepharitis at Day 28. Started Dec 2010; status: terminated.
02
Drugs
AzaSite
03
Conditions
blepharitis
Beyond the preview
Go deeper on NCT01269658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01269658.